Invizyne Technologies Inc. Common Stock
Invizyne Technologies, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The c… Read more
Market Cap & Net Worth: Invizyne Technologies Inc. Common Stock (IZTC)
Invizyne Technologies Inc. Common Stock (NASDAQ:IZTC) has a market capitalization of $111.96 Million ($111.96 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #40857 globally and #13251 in its home market, demonstrating a 18.09% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Invizyne Technologies Inc. Common Stock's stock price $11.75 by its total outstanding shares 9528800 (9.53 Million).
Invizyne Technologies Inc. Common Stock Market Cap History: 2024 to 2025
Invizyne Technologies Inc. Common Stock's market capitalization history from 2024 to 2025. Data shows growth from $157.23 Million to $111.96 Million (0.00% CAGR).
Index Memberships
Invizyne Technologies Inc. Common Stock is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #2880 of 3165 |
Weight: Invizyne Technologies Inc. Common Stock's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Invizyne Technologies Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Invizyne Technologies Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of IZTC by Market Capitalization
Companies near Invizyne Technologies Inc. Common Stock in the global market cap rankings as of March 19, 2026.
Key companies related to Invizyne Technologies Inc. Common Stock by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Invizyne Technologies Inc. Common Stock Historical Marketcap From 2024 to 2025
Between 2024 and today, Invizyne Technologies Inc. Common Stock's market cap moved from $157.23 Million to $ 111.96 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $111.96 Million | -28.79% |
| 2024 | $157.23 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Invizyne Technologies Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $111.96 Million USD |
| MoneyControl | $111.96 Million USD |
| MarketWatch | $111.96 Million USD |
| marketcap.company | $111.96 Million USD |
| Reuters | $111.96 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.